Boc-beta-(2-thienyl)-D-Ala-OH · DCHA

Boc-beta-(2-thienyl)-D-Ala-OH · DCHA is a Boc-protected, D-configured alanine derivative bearing a beta-(2-thienyl) substituent, supplied as a dicyclohexylamine (DCHA) salt form. This combination of a protected amino group and a substituted, heteroaryl side chain makes it a practical building block for assembling modified peptides and for preparing chiral, aromatic-containing intermediates used in medicinal chemistry programs.

1. Modified Peptide Building Block

Boc-beta-(2-thienyl)-D-Ala-OH · DCHA is used as a protected amino acid building block for peptide synthesis workflows that require incorporation of a beta-(2-thienyl) alanine motif. Researchers in custom peptide manufacturing and peptide chemistry labs select this reagent when they need a D-amino acid stereocenter paired with a heteroaryl substituent to tune local conformation, steric profile, and aromatic character in the resulting peptide sequence. The Boc-protected amino functionality supports standard protected-amino-acid coupling strategies used to generate peptide intermediates and final peptides containing non-proteinogenic residues.

2. Medicinal Chemistry Peptidomimetic Intermediates

Boc-beta-(2-thienyl)-D-Ala-OH · DCHA is commonly deployed in medicinal chemistry to prepare peptidomimetic fragments and constrained analogs where a beta-heteroaryl alanine unit is used as a structural element. Medicinal chemistry groups use this type of building block to generate SAR libraries that explore how an appended 2-thienyl group influences physicochemical properties and molecular recognition patterns in peptide-like scaffolds. The D-configuration and the beta-substitution pattern provide a stereochemical and structural handle that is frequently leveraged when designing non-natural amino acid-containing analogs for downstream synthesis into larger compounds.

3. Chiral Aromatic Amino Acid Synthesis

Boc-beta-(2-thienyl)-D-Ala-OH · DCHA serves as a chiral, aromatic-containing intermediate for developing specialty amino acid derivatives and downstream heteroaryl-substituted building blocks. Process and R&D chemists use this reagent when they need a reliably protected, stereodefined precursor that already contains the 2-thienyl substituent at the beta position, reducing the need to introduce the heteroaryl group late in a synthetic sequence. The DCHA salt form is also leveraged in some industrial and scale-up contexts to improve handling characteristics of the protected amino acid intermediate during weighing, dissolution, and material transfer steps.

4. Solid-Phase Peptide Segment Assembly

Boc-beta-(2-thienyl)-D-Ala-OH · DCHA is applied in segment assembly approaches where protected amino acid residues are incorporated into peptide chains bearing non-natural beta-substituted motifs. Peptide synthesis teams use this reagent to construct defined peptide segments that later undergo further coupling or deprotection steps, enabling controlled placement of the beta-(2-thienyl) D-Ala residue within a sequence. The presence of the Boc protecting group supports its role as a residue-level input for building complex modified peptides used in chemical biology studies and materials-oriented peptide design.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats